Cardiff Lexington Corp (CDIX)
Cardiff Lexington Corp (CDIX)
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | -3,092,074 | -2,686,121 | -1,144,299 | -1,226,395 |
| Bonus expense settled with promissory notes | NaN | 593,450 | NaN | NaN |
| Depreciation | 593 | 762 | 762 | 763 |
| Gain on settlement or forgiveness of debt | NaN | 0 | 0 | 0 |
| Share issuance for compensation to directors and officers | NaN | NaN | 28,688 | 0 |
| Change in estimate for settlement realization rate | NaN | 0 | 0 | NaN |
| Interest included in line of credit | NaN | NaN | 1,713,188 | 1,441,975 |
| Amortization of debt discounts | 11,438 | 0 | 24,821 | NaN |
| Amortization of debt discount | NaN | NaN | NaN | 0 |
| Gain on resolution and disposition of discontinued operations claims | NaN | 238,285 | NaN | NaN |
| Conversion and note issuance cost | NaN | 0 | 1,500 | 0 |
| Credit losses | 0 | 150,201 | 0 | 0 |
| Loss on disposal of assets | 0 | 0 | 0 | 0 |
| Loss on issuance / change in fair value of derivative liability | -668,821 | NaN | NaN | NaN |
| Interest included in line of credit | 1,955,970 | 6,421,521 | NaN | NaN |
| Accrued officers compensation | NaN | 343,135 | 57,166 | 56,545 |
| Share issuance and compensation expense | 664,196 | 644,475 | 12,500 | 97,500 |
| Accounts receivable | 819,945 | 1,521,156 | 1,506,580 | 1,691,365 |
| Right of use assets | -59,621 | -66,656 | -75,334 | -75,279 |
| Prepaids and other current assets | 79,060 | 87,390 | -4,965 | 2,771 |
| Accounts payable and accrued expense | 224,261 | 172,578 | 167,333 | -110,753 |
| Accrued related parties compensation | 410,629 | NaN | NaN | NaN |
| Accrued interest | 39,017 | 139,588 | 90,946 | 35,438 |
| Right of use liabilities | -60,197 | -68,229 | 111,934 | -73,799 |
| Net cash used in operating activities | NaN | -389,974 | -574,297 | -1,397,583 |
| Net cash provided by discontinued operations operating | NaN | 0 | 0 | 0 |
| Net proceeds from line of credit | NaN | 353,669 | 323,808 | 1,037,733 |
| Payments to director | NaN | 0 | 0 | 0 |
| Payments on convertible notes payable | NaN | 0 | 0 | 0 |
| Net cash used in operating activities | -16,730 | NaN | NaN | NaN |
| Repayment of sba loans | 2,193 | 2,193 | 2,193 | 2,193 |
| Net (payments) proceeds on line of credit | -243,705 | NaN | NaN | NaN |
| Proceeds from convertible notes payable | 845,000 | 200,000 | NaN | NaN |
| Payments of debt issuance costs | 142,400 | NaN | NaN | NaN |
| Payments on note payable | 75,000 | 75,000 | 75,000 | 75,000 |
| Payment of dividends on preferred stock | 0 | 0 | 0 | 100,000 |
| Net cash provided by financing activities | 381,702 | 476,476 | 246,615 | 960,540 |
| Net increase (decrease) in cash | 364,972 | 86,502 | -327,682 | -437,043 |
| Cash, beginning of period | 318,535 | 232,033 | 1,188,185 | NaN |
| Cash, end of period | 683,507 | 318,535 | 232,033 | NaN |